Edge Medical Cuts Free-Float by 0.07% Through HKD 6.80 Million H-Share Buyback

Bulletin Express19:41

Shenzhen Edge Medical Co., Ltd. (Edge Medical) disclosed a share repurchase on 22 October 2026 under its existing mandate.

• Transaction details – Shares repurchased: 217,600 H-shares – Purchase venue: Hong Kong Stock Exchange – Price range: HKD 30.66–32.00 per share – Aggregate consideration: HKD 6.80 million

• Capital structure impact – Issued shares (excluding treasury shares) fell from 324.18 million to 323.96 million, a 0.07% reduction. – Treasury-share balance rose to 3.80 million. – Total issued share capital remains at 327.76 million shares; the repurchased shares are being held in treasury.

• Mandate utilisation – Shareholders approved a buyback mandate on 25 June 2026 for up to 32.61 million shares. – Including the latest purchase, cumulative repurchases under the mandate total 2.19 million shares, equal to 0.67% of the issued share base on the mandate’s approval date. – In line with Listing Rules, Edge Medical is restricted from issuing new shares or transferring treasury shares until 21 November 2026.

The board confirmed that all regulatory requirements were satisfied in executing the repurchase. No shares have yet been cancelled.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment